Healthcare and Life Science
Enterprise Therapeutics appoints Annabella Amatulli as Head of Regulatory Affairs
Appointment brings extensive regulatory experience as lead asset ETD001 progresses through Phase 2 clinical trial for treatment of cystic fibrosis Brighton, UK, 11 September 2024: Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and devel...
Engagement and motivation at work: what's the difference?
At work, you’ve probably heard people throwing around the terms “motivation” and “engagement” like they’re the same thing. Spoiler alert: They’re not. While both are crucial for driving employee performance and satisfaction, they represent distinct aspects of how we experience the workp...
Health Innovation East and 42T webinar to help power Net Zero NHS
Health Innovation East, the innovation arm of the NHS in the East of England and 42 Technology (42T), a product design and innovation consultancy, are co-hosting a free webinar aimed at helping the NHS achieve its ambitious net zero goals. ...
PhoreMost extends Series B financing to $50M to advance high-value oncology and inflammation degrader programmes
Investment to enable progression of pipeline of novel degrader assets through pre-clinical development and support further development of GlueSEEKER™ platform Led by Parkwalk Advisors alongside existing investors BGF, Dr Jonathan Milner, Amadeus Capital and Astellas Venture Manageme...
NanoSyrinx closes c. £10 million GBP financing and appoints Dr. Edwin Moses as Chairman
Round co-led by BGF, Octopus Ventures and M Ventures, with support from new corporate investor, Eli Lilly and Company, and existing investors, IQ Capital and Meltwind Appointment of Edwin Moses as Chairman to support the leadership team in maximising the value of the technology plat...
HOPE: Cleanroom Solutions facilitating greatness with elite large-scale turnkey construction builds
Guardtech Group’s complex cleanroom facility construction brand celebrating their role as facilitators of groundbreaking Life Science and R&D innovation ...
Meet Cambridge helps to bring international neurotrauma conference to the city
The official bureau for conferences and events in Cambridge and the surrounding area is seeing the culmination of five years’ preparation as partner to the organising committee for one of the world’s largest medical conferences in its field. ...
Newcells Biotech launches Lung Ciliary Beat Frequency assay to enhance safety and efficacy profiling in preclinical drug development
Application of new CiliaBeat software to provide reliable and predictive data on the impact of drugs on cilia function Assay leverages Newcells’ complex lung small airway in vitro model to enable highly sensitive assessment of drug efficacy and chemical safety as part of expanded se...
Overcoming obstacles in medical device innovation
Co-authored by Samantha Shelley, SQMS
Unlocking opportunities in China's thriving Life Sciences market
As the second-largest healthcare market in the world, China is on an extraordinary trajectory of growth, with its life sciences sector expected to triple in size by 2030. This is an exciting time for UK life science companies looking to expand their horizons. Excellence First Enterprise...